Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.058 | 0.8 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |